Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
dHACM for incisional hernia prophylaxis
NCT04417140Phase 4Unknown
- Sponsor
- Louisiana State University Health Sciences Center
- Start
- May 2020
- Primary completion
- May 2022
- Modality
- Implantable Devices, Implantable Hydrogels, Tissue Cells
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of AmnioFix in incisional hernia (2 arms), sponsored by Louisiana State University Health Sciences Center. Primary endpoint: Incidence of Incisional Hernia at 6 months. Status: unknown.
02
Drugs
AmnioFix
03
Conditions
incisional hernia
Beyond the preview
Go deeper on NCT04417140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04417140.